Another European company went to China.
Editor’s note: This article is from WeChat public account “Investment” (ID: pedaily2012 ), author Ren Qian Yang Li. The original topic “Surgery 14,000 yuan, the eye clinic giant Hong Kong IPO, the market value of more than 3.5 billion Hong Kong dollars”
After Budweiser Asia Pacific, another European company went to China and knocked on the door of the Hong Kong Stock Exchange.
Investment (WeChat ID: pedaily2012) On October 15th, Euroeyes officially listed on the Hong Kong Stock Exchange, the offer price was originally set at 7.50 Hong Kong dollars, the opening price was 14.2 Hong Kong dollars, the first day opened higher than 50%, before the deadline for publication, the market value exceeded 3.5 billion Hong Kong dollars.
Founded 26 years ago and entered China for 6 years. As the leading eye group in Europe, Deshijia began to turn its attention to China after setting the first throne in Germany. It has successfully become the first German company to go to Hong Kong IPO, and is the only foreign company in Hong Kong that provides medical professional services. DeTV is targeting nearly 600 million people in China.
European ophthalmology master founded,corrective surgery from 14,000 yuan, 2018 net profit 斩 斩
Derby is founded by Dr. Jorgensen, a leading eye scientist in Germany, with some legends behind it.
Dr. Jorgensen was born in Denmark and has worked in many countries and has gradually developed an interest in the field of refractive surgery. In 1990, he successfully underwent cataract surgery using minimally invasive techniques (phacoemulsification cataract extraction). Less than a year later, he introduced the “incision seamless line cataract surgery”.
In 1993, the first Deshijia clinic was established in Hamburg, Germany.